DIGOXIN 125 MCG TABLET
For 30 tablets
Pharmacies pay
$3.98 filed
30 × $0.1327 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$12.99 filed
30 × $0.433 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.3× estimated
Medicare paid 3.3× what pharmacies pay.
Part D averages every strength and form sold under “Digoxin*” / “Digoxin” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$9.58 estimated
$3.98 + $0.60 (15%) + $5.00 fee per fill = $9.58
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DIGOXIN 125 MCG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as digoxin.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Major Pharmaceuticals and AvPAK.
FDA’s Established Pharmacologic Class for it is Cardiac Glycoside.
The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 13 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.98 for 30 tablets (30 × $0.1327 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 2 | $0.1327 per EA filed |
| Amneal Pharmaceuticals NY LLC | 2 | $0.1327 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.1327 per EA filed |
| Hikma Pharmaceuticals USA Inc. | 2 | $0.1327 per EA filed |
| Oliva Therapeutics, LLC | 2 | $0.1327 per EA filed |
| American Health Packaging | 1 | $0.1327 per EA filed |
| AvPAK | 1 | $0.1327 per EA filed |
| Major Pharmaceuticals | 1 | $0.1327 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.1327 per EA filed |
All 15 NDCs, with labeler and price
- 00143-1240-01 · Hikma Pharmaceuticals USA Inc. · $0.1327 per EA · eff. 2026-09-23 filed
- 00143-1240-10 · Hikma Pharmaceuticals USA Inc. · $0.1327 per EA · eff. 2026-09-23 filed
- 00904-5921-61 · Major Pharmaceuticals · $0.1327 per EA · eff. 2026-09-23 filed
- 50268-0238-11 · not listed as a package in the FDA directory · $0.1327 per EA · eff. 2026-09-23 filed
- 50268-0238-15 · AvPAK · $0.1327 per EA · eff. 2026-09-23 filed
- 59651-0437-01 · Aurobindo Pharma Limited · $0.1327 per EA · eff. 2026-09-23 filed
- 59651-0437-99 · Aurobindo Pharma Limited · $0.1327 per EA · eff. 2026-09-23 filed
- 60687-0858-01 · American Health Packaging · $0.1327 per EA · eff. 2026-09-23 filed
- 60687-0858-11 · not listed as a package in the FDA directory · $0.1327 per EA · eff. 2026-09-23 filed
- 69238-1991-01 · Amneal Pharmaceuticals NY LLC · $0.1327 per EA · eff. 2026-09-23 filed
- 69238-1991-07 · Amneal Pharmaceuticals NY LLC · $0.1327 per EA · eff. 2026-09-23 filed
- 70954-0201-10 · ANI Pharmaceuticals, Inc. · $0.1327 per EA · eff. 2026-09-23 filed
- 70954-0201-20 · ANI Pharmaceuticals, Inc. · $0.1327 per EA · eff. 2026-09-23 filed
- 82685-0201-01 · Oliva Therapeutics, LLC · $0.1327 per EA · eff. 2026-09-23 filed
- 82685-0201-10 · Oliva Therapeutics, LLC · $0.1327 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name digoxin with DIGOXIN 125 MCG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DIGOXIN 0.05 MG/ML SOLUTION | $1.14686 per ML filed | We don’t know yet |
| DIGOXIN 62.5 MCG TABLET | $8.59432 per EA filed | $0.433 per EA filed |
| DIGOXIN 125 MCG TABLET this page | $0.1327 per EA filed | $0.433 per EA filed |
| DIGOXIN 250 MCG TABLET | $0.14843 per EA filed | $0.433 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $12.99 for 30 tablets, at an average of $0.433 per EA in 2024 (2024-01-01 to 2024-12-31) for “Digoxin*” and “Digoxin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,579,920 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for DIGOXIN 125 MCG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Digoxin* / Digoxin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 33 NADAC NDCs the name join matched to it have an FDA route including ORAL. 3 of the 30 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 30 of 33 NADAC NDCs joined to this name are priced per EA (3 per ML): CMS's average mixes those units.